Assessing Safety and Efficacy of Preoperative and Post-Transplant C1 Inhibitor (Berinert) vs. Placebo in Recipients of a Renal Allograft From Deceased High Risk Donors and Its Impact on DGF and IRI
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 02 Aug 2017
At a glance
- Drugs Complement C1 inhibitor protein (Primary)
- Indications Delayed graft function; Reperfusion injury
- Focus Therapeutic Use
- 28 Jul 2017 Planned End Date changed from 1 Jun 2017 to 1 Jan 2018.
- 16 Feb 2017 Planned End Date changed from 1 Jun 2019 to 1 Jun 2017.
- 16 Feb 2017 Planned primary completion date changed from 1 Jun 2018 to 12 Apr 2017.